Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cell-mediated Immune Responses01:40

Cell-mediated Immune Responses

Overview
Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Cytomegalovirus Disease01:27

Cytomegalovirus Disease

Cytomegalovirus (CMV) disease is caused by human cytomegalovirus, a double-stranded DNA virus of the Herpesviridae family. While primary CMV infection is often asymptomatic in immunocompetent individuals, the virus can cause severe disease in neonates and immunocompromised patients. CMV is the most common cause of congenital viral infection in the United States, and a major pathogen in solid organ and hematopoietic stem cell transplant recipients.CMV is transmitted via bodily fluids, sexual...
Immune Response Against Viral Pathogens01:29

Immune Response Against Viral Pathogens

The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
Antigens Involved in Adaptive Immunity01:26

Antigens Involved in Adaptive Immunity

An antigen is any substance the immune system identifies as foreign and potentially harmful to the body, prompting an immune response. Antigens have two functional properties: immunogenicity and reactivity. Immunogenicity is the ability of an antigen to stimulate a specific immune response. At the same time, reactivity describes the antigen's ability to react with the cells and antibodies produced in response to it.
Complete Antigens
Complete antigens possess both immunogenicity and reactivity.
B Cell Activation and Differentiation01:24

B Cell Activation and Differentiation

The adaptive immune response, a sophisticated defense mechanism, relies on the activation and differentiation of B lymphocytes, or B cells. These processes enable our bodies to mount a tailored response against specific pathogens such as bacteria, free virus particles, toxins, and parasites.
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Evidence for the Collective Nature of Radial Flow in Pb+Pb Collisions with the ATLAS Detector.

Physical review letters·2026
Same author

Evidence for the Dimuon Decay of the Higgs Boson in pp Collisions with the ATLAS Detector.

Physical review letters·2025
Same author

Evidence for Longitudinally Polarized W Bosons in the Electroweak Production of Same-Sign W Boson Pairs in Association with Two Jets in pp Collisions at sqrt[s]=13  TeV with the ATLAS Detector.

Physical review letters·2025
Same author

Observation of tt[over ¯] Production in Pb+Pb Collisions at sqrt[s_{NN}]=5.02  TeV with the ATLAS Detector.

Physical review letters·2025
Same author

Search for Dark Matter Produced in Association with a Dark Higgs Boson in the bb[over ¯] Final State Using pp Collisions at sqrt[s]=13  TeV with the ATLAS Detector.

Physical review letters·2025
Same author

Search for Magnetic Monopole Pair Production in Ultraperipheral Pb+Pb Collisions at sqrt[s_{NN}]=5.36  TeV with the ATLAS Detector at the LHC.

Physical review letters·2025

Related Experiment Video

Updated: Jun 24, 2026

Use of Interferon-γ Enzyme-linked Immunospot Assay to Characterize Novel T-cell Epitopes of Human Papillomavirus
13:41

Use of Interferon-γ Enzyme-linked Immunospot Assay to Characterize Novel T-cell Epitopes of Human Papillomavirus

Published on: March 8, 2012

Cell-mediated immunity in cervical cancer evolution.

A Jandová1, J Pokorný, J Kobilková

  • 1Institute of Photonics and Electronics, Academy of Sciences, Prague, Czech Republic.

Electromagnetic Biology and Medicine
|April 2, 2009
PubMed
Summary
This summary is machine-generated.

Cell-mediated immunity (CMI) differs between healthy women and those with cervical cancer or precancerous lesions. This immune response may indicate changes in mitochondrial activity associated with cervical carcinoma.

More Related Videos

Four-color Fluorescence Immunohistochemistry of T-cell Subpopulations in Archival Formalin-fixed, Paraffin-embedded Human Oropharyngeal Squamous Cell Carcinoma Samples
07:43

Four-color Fluorescence Immunohistochemistry of T-cell Subpopulations in Archival Formalin-fixed, Paraffin-embedded Human Oropharyngeal Squamous Cell Carcinoma Samples

Published on: July 29, 2017

Generation and Genetic Manipulation of Human Cervical Organoids
10:29

Generation and Genetic Manipulation of Human Cervical Organoids

Published on: March 10, 2026

Related Experiment Videos

Last Updated: Jun 24, 2026

Use of Interferon-γ Enzyme-linked Immunospot Assay to Characterize Novel T-cell Epitopes of Human Papillomavirus
13:41

Use of Interferon-γ Enzyme-linked Immunospot Assay to Characterize Novel T-cell Epitopes of Human Papillomavirus

Published on: March 8, 2012

Four-color Fluorescence Immunohistochemistry of T-cell Subpopulations in Archival Formalin-fixed, Paraffin-embedded Human Oropharyngeal Squamous Cell Carcinoma Samples
07:43

Four-color Fluorescence Immunohistochemistry of T-cell Subpopulations in Archival Formalin-fixed, Paraffin-embedded Human Oropharyngeal Squamous Cell Carcinoma Samples

Published on: July 29, 2017

Generation and Genetic Manipulation of Human Cervical Organoids
10:29

Generation and Genetic Manipulation of Human Cervical Organoids

Published on: March 10, 2026

Area of Science:

  • Immunology
  • Oncology
  • Cell Biology

Background:

  • Cell-mediated immunity (CMI) plays a crucial role in host defense against infections and cancer.
  • Alterations in CMI are observed in various malignancies, including cervical cancer.
  • Understanding CMI in cervical precancerous lesions and cancer is vital for diagnosis and treatment.

Purpose of the Study:

  • To investigate and compare cell-mediated immunity (CMI) responses to specific and non-specific antigens in healthy women, patients with cervical precancerous lesions (cervical intraepithelial neoplasia - CIN), and cervical cancer patients.
  • To explore the relationship between CMI status and the grade of cervical intraepithelial neoplasia (CIN).
  • To assess potential links between cervical carcinoma development and mitochondrial activity.

Main Methods:

  • Cell-mediated immunity (CMI) was assessed using the leukocyte adherence inhibition (LAI) assay.
  • Specific antigen derived from cervical carcinoma tissue and a non-specific antigen from lactate dehydrogenase (LDH) virus-infected mouse blood were employed.
  • Diagnosis of cervical lesions was confirmed via cytological (PAP) smears, colposcopy, and histological examination of punch biopsies.

Main Results:

  • Significant differences in CMI responses were observed between healthy women and cervical cancer patients when exposed to specific and non-specific antigens.
  • CMI responses in patients with cervical intraepithelial neoplasia (CIN) grades 1-3 mirrored those of either healthy women or cervical cancer patients, with a similar distribution across CIN groups.
  • The effect of the non-specific antigen suggested a potential reduction in mitochondrial activity during cervical carcinoma transformation, comparable to processes seen in LDH virus infection.

Conclusions:

  • Cell-mediated immunity (CMI) profiles differ notably between healthy individuals and those with cervical cancer, offering potential diagnostic or prognostic markers.
  • CMI responses in precancerous cervical lesions (CIN) are heterogeneous, aligning with either healthy or cancerous states, irrespective of CIN grade.
  • Cervical carcinoma development may involve a reduction in mitochondrial activity, potentially linked to viral infections like LDH virus, impacting CMI.